Pushpawati Singhania Research Institute is a trusted healthcare provider for Management of Seizures, offering comprehensive seizure and epilepsy care supported by experienced neurologists, epileptologists, neurosurgeons, neurophysiology specialists, and multidisciplinary teams. Established in 1996, the NABH, NABL- accredited hospital is situated in Delhi, India and has 201 beds.

Management of Seizures aims to control seizure activity, reduce the risk of injury and recurrence, and address the underlying condition when identifiable. Antiseizure medications are commonly used, with the choice depending on seizure type, age, medical history, potential drug interactions, and other patient-specific factors. For drug-resistant epilepsy, selected patients may be evaluated for epilepsy surgery, vagus nerve stimulation, responsive neurostimulation, or other advanced treatment options.